LIMNW

Liminatus Pharma Warrants
LIMNW

1 day
5 days
1 month
3 months
6 months
Year to date
1 year
5 years
10 years
 

About: Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Healthcare Biotechnology
0
Funds holding %
of 7,506 funds
Explore Fund Trends
–
Analysts bullish %
See Analyst Outlook
–
Positive news %
Check Journalist POV
Price charts implemented using Lightweight Charts™